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Background: Cognitive dysfunction, include reduced 
mental alertness, intellectual impairment, decreased 
attention and concentration, memory deficits and 
diminished perceptual-motor coordination. Both CKD 
and chronic dialysis patients are thought to be associated 
with cognitive impairment. Cognitive impairment may 
decrease an individual's quality of life, increase resource 
utilization and result in suboptimal medical care. 
Neurophysiologic tests using imaging techniques are 
used to evaluate structural and functional abnormalities. 
Neuropsychological testing uses validated questions and 
screening tests to evaluate cognition.  
 
Setting and participants: This study was carried out on 
120 patients with different stages of CKD from 
nephrology outpatient clinic and hemodialysis unit in 
Ain Shams University Hospitals. Group I: 50 CKD 
patients, stage Ш and stage IV. Group II: 50 ESRD 
patients on regular hemodialysis with K t/v > 1.1. Group 
III: 20 acute kidney injury patients, followed up till their 
renal functions stabilized. Group ІV: 20 healthy subjects 
matched with patients. All patients underwent laboratory 
investigations and psychometric tests which include trial 
making test part B, digit  span  test, digit symbol test, 
mini-mental state examination.  
 
Results: There were highly significant differences of  
mean values of cognitive function tests between (groups 
I,II and III as compared with group IV (control group),  
stage III CKD and stage IV CKD, CKD and 
hemodialysis patients, AKI patient at the insult and after 
recovery) and finally between  hemoglobin and cognitive 
function tests score.  
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Conclusions: There were significant differences of 
cognitive function tests results between CKD, III,IV,V, 
AKI patients as compared with healthy group, suggesting 
that kidney disease affects cognitive performance, there 
were significant differences of cognitive function tests 
results between stage III CKD and stage IV CKD, 
suggesting that the degree of cognitive impairment is 
associated with the severity of CKD, also significant 
differences of cognitive function tests results between 
CKD and ESRD on hemodialysis, suggesting that 
dialysis improves cognitive performance. Our results 
showed significant differences of cognitive function tests 
results between AKI patients at the insult and after 
recovery, suggesting that AKI also impair cognitive 
function. Finally cognitive performance is affected by 
hemoglobin level in CKD stage III, IV, V on 
hemodialysis and AKI patients, suggesting that treatment 
of anemia in AKI, CKD and ESRD patients improve 
cognitive performance.  
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Cognition is the mental faculty or process of acquiring 
knowledge by the use of reasoning or perception. 
Cognition is the foundation that underlies all daily 
activities, from the most basic to the most complex [1]. 
Cognitive impairment and chronic kidney disease (CKD) 
will become increasingly prevalent in the aging 
population.  The incidence of kidney failure is rising in 
all age groups but particularly in older adults. Individuals 
with different stages of CKD are at higher risk for 
development of cognitive impairment and this may be a 
major determinant in their quality of life. Cognitive 
dysfunction includes reduced mental alertness, 
intellectual impairment, decreased attention and 
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concentration, memory deficits and diminished 
perceptual-motor coordination [2]. Cognitive impairment 
is associated with an increased risk of death in dialysis 
patients. Cerebrovascular disease is a strong risk factor 
for development of cognitive impairment and vascular 
disease is a more likely cause of cognitive impairment 
than Alzheimer's disease in patients with CKD. Both 
traditional and nontraditional vascular risk factors are 
more common in CKD and dialysis patients may also be 
at risk for cognitive impairment via nonvascular risk 
factors and the hemodialysis procedure itself [3]. The 
severity of kidney disease was associated with the 
severity of cognitive impairment, independent of age, 
education and other key confounders [4]. CKD is 
associated with other risk factors for cognitive 
impairment, including advanced age, diabetes, 
hypertension and dyslipidemia. Cognitive impairment in 
patients with CKD also may be mediated by the retention 
of putative neurotoxins, including byproducts of nitrogen 
metabolism and parathyroid hormone. Chronic 
inflammation is well known in CKD patients, and is a 
risk factor for development of dementia in them [5]. It is 
important to identify those patients with cognitive 
impairment to reduce the considerable morbidity 
associated with this condition and improve their quality 
of life [6]. Both CKD and chronic dialysis patients are 
associated with cognitive impairment but cognitive 
function improves following initiation of dialysis and 
dialysis patients have less cognitive impairment 
compared to untreated patients with advanced uremia. 
Studies have also found improvement in short-term 
memory both after starting maintenance hemodialysis 
and following a single hemodialysis treatment and 
attention functions have been found to improve after 
starting maintenance dialysis. However, cognitive 
dysfunction, including reduced concentration capacity, 
learning and memory as well as cognitive inflexibility 
and impaired complex novel problem solving, is 
commonly reported to persist in dialysis patients [7]. 
Some absolute levels of cognitive function were found to 
be associated with the adequacy of dialysis. In particular, 
the attention and concentration test scores were found to 
be predicted by the adequacy of dialysis, suggesting that 
these tests may be most sensitive as an impact of renal 
functioning [8].  
Two broad classes of tests are used to assess cognitive 
function in the general population (table 1,2). 
Neurophysiological testing uses imaging techniques and 
electrophysiology to evaluate structural and functional 
abnormalities. Neuropsychological testing uses validated 
questions and screening tests to evaluate cognition [9].  
Four tests were administered in our study. First, the trail 
making test part B (TMT-B) which assesses attention, 
visual scanning, psychomotor speed, ability to sequence 
and ability to shift cognitive set [10].  Second, the digit 
span test (D-span) which is a widely used auditory verbal 
short-term (working) memory test. Third, the digit 
symbol test (D-symbol) which tests the sustained 
attention, visual searching, and new-learning abilities of 
the patients [11]. Fourth, the mini-mental state 
examination (MMSE) which assesses orientation, 
registration, attention, calculation, recall, and language 
[12,13]. 
Our study aims to assess the cognitive function in CKD 
stage III and IV, Stage V on hemodilaysis (HD) and 
AKI, and correlates it with hemoglobin level. In addition 
we study the changes in the cognitive function following 
dialysis treatment. 
 
Material and methods 
 
This study was carried out on 120 patients with different 
stages of kidney disease. They were divided into 3 
groups: 
Group I:  Included 50 CKD patients 28 of them with 
stage Ш and 22 with stage IV selected from nephrology 
outpatient clinic. 
Group II:  Included 50 patients on regular hemodialysis 
thrice weekly (4 hours each session) with K t/v > 1.1.  
Group III: Included 20 patients with acute kidney injury. 
They were followed up till their renal functions 
recovered. 
Group ІV: Included 20 healthy subjects matched with 
patients as regards age, sex and education. 
Patients with evident cerebrovascular disease, thyroid 
disease, severe anemia, uncontrolled hypertension, 
malnutrition, major psychiatric illness, major visual or 
hearing impairment, unstable coronary heart disease, 
collagen vascular disease and vasculitis were excluded 
from the study. All the medications were revised to 
exclude any drugs that had an affect on the cognitive 
function. 
All patients underwent: 
1. Through history, clinical examination and laboratory 
investigations.  
2. Psychometric tests  was done in dialysis off day 
which include: 
TMT-B: The trial making test part B requires that the 
subject connect with lines, in a given sequences, circled 
digits and letters randomly distributed on a page as 
shown in figure 1. The prescribed sequence is from 1 to 
A to 2 to B to 3 to C, etc. Performance is scored in terms 
of time to complete the task correctly. The TMT-B 
assesses attention, visual scanning, psychomotor speed, 




Fig.  1. TMT-B. 
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 D-span: The digit span test is a widely used auditory 
verbal short-term (working) memory test. It requires 
the subject to repeat a spoken string of digits, two 
trials each, for stings three to nine digits in the 
forward order and two to eight digits in the reverse 
order. The score is the number of correct trials. 
 D-symbol: It tests the sustained attention, visual 
searching, visual sequencing and new learning 
abilities of the patients. Subjects were given nine 
different symbols that were matched to numbers and 
they were required to change the number with its 
matched symbol as shown in figure 2. The score is 








The mini-mental state examination as shown in table 1, is 
a widely used well validated screening tool for cognitive 
impairment. It tests five areas of cognitive function. The 
first area of cognitive function, orientation, is assessed by 
asking the usual questions about time, day, date and 
location. Second area of cognitive function, registration, 
is actually a short term memory test where the subject 
must recall three objects named by the examiner. Third 
and fourth area, attention and calculation, are measured 
by having the subject begin with 100 and count 
backwards by 7 (serial 7s). Recall, the subject must recall 
the three objects named previously. Language functions 
are assessed by having the subject name simple objects, 
repeat a sentence and follow a three stage command. A 
constructional task is also included in the language 
section where the subject must copy overlapping 
pentagons. Each discrete subtask completed correctly 
earns 1 point toward a maximum score of 30. Mild 
cognitive impairment score is between 26 -28, moderate 
cognitive impairment score is between 18-25, while 
severe impairment is below 18. 
The statistical analysis: Done by using Excel program 
and SPSS program statistical package for social science 
version 10. The description of the data was done in form 
of mean (+/-) SD for quantitative data. The analysis of 
the data was done to test statistical significant difference 
between groups. For quantitative date student t-test was 
used to compare between 2 groups paired sample t-test 
was used to compare one group at different 
measurements. One way Anova test was used to compare 
more than 2 groups. Pearson correlation Co-efficiency 
test was used to test association between variables. 
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Table 1. MMSE.  
 
Items on the Mini-Mental State Examination [12,13].   
 








What is the (year) (season) (date) (day) (month)? 







Name 3 objects: (1 second to say each). Ask the patient 
for all 3 after you have said them. Give 1 point for each 
correct answer. Then repeat them until the patient 
learns all three. Count the trials and record. 
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Attention and calculation 
Serial subtraction of 7. 1 point for each correct. Stop 












Name a pencil; name a watch 
Repeat the following ―No ifs, ands, or buts.‖ 
Follow a three stage command:‖Take a paper in your 
right hand, fold it in half, and put it on the floor.‖ 
Read and obey the following:‖Close your eyes.‖ 
Write a sentence 













Population characteristics: This study included 120 
patients divided into 3 groups. Group I which included 
50 CKD patients in stage III and stage IV CKD. Stage III 
CKD included 28 patients, 53.6%) males and 46.4% 
females. The mean age was 44.75±10.157 years old. 
Mean education years was 8.1429±3.56645 years. Stage 
IV CKD included 22 patients, 40.9% males and 59.1% 
females. The mean age was 45.59±11.677 years old. 
Mean education years was 6.2273±3.77879 years.  
Group II which included 50 CKD patients stage V on 
regular hemodialysis, 54% males and 46% females. The 
mean age was 40.42 ± 12.588 years old.  Mean education 
years   was 8.66±3.685 years. The mean dialysis duration 
was 4.64±3.148 years. The etiology of ESRD in the 
participating subjects is hypertension (48%), diabetes 
(38%), congenital (6%), glomerulonephritis (4%), 
analgesic (2%), and obstructive uropathy (2%). 
Group III, which included 20 acute kidney injury (AKI), 
60% males and 40% females. They were studied 
throughout the course of their illness till their renal 
function stabilized. The mean age was 45.35±10.163 
years old. Mean education years was 8.2±3.381 years. 
The etiology of AKI in the participating subjects is 40% 
due to drug induced, 20% blood loss, and 40 % due to 
fluid loss from gastrointestinal tract.   
In addition, there was group IV (control group), which 
included 20 healthy subjects; 50% males and 50 % 
females. The mean age was 39.6 ± 10.096 years old. 
Mean education years was 9.35±2.961 years. 
Table 2 shows, that there is highly significant differences 
between mean values of cognitive function tests of 
groups I,II and III as compared with group IV (control 
group) as indicating that uremia has a major influence on 
the cognitive function in CKD patients. 
 
 
Table 2. Comparison between mean values of cognitive function tests of group I, II, III, as compared with control group. 
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Our study clarifies that dialysis improves the cognitive function as patients under regular efficient hemodialysis for more 
than 1 year  perform better  in the  tests of evaluation of cognitive function than the predilysis patients with stage III, and 
Stage IV CKD as shown in table 4. 
 








































































Although there are limited studies on AKI and cognitive function, our 20 patients with AKI had mild cognitive impairment 
and was corrected within the recovery of kidney function as shown in table 5. 
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Pair 2      TMT-B 
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Pair 4      D.SPAN 









Anemia is one of the factors responsible for cognitive dysfunction in predialysis CKD, hemodialysis patients, and AKI 






































In CKD stage V on hemodialysis there was  a highly significant correlation between hemoglobin and cognitive function 
tests score, as shown in table 8. 
 



































Table 8. Correlation between hemoglobin and cognitive function tests in AKI patients. 
 































In hemodialysis patients there was no significant correlation between dialysis duration and cognitive function tests score as 
shown in table 9. 
 












Dialysis  duration  pearson correlation  






















Cognitive impairment is a well-recognized manifestation 
of uremia. This is characterized by quiet stupor, dullness 
of intellect, sluggishness of manner, and drowsiness [5]. 
The severity of kidney disease is associated with the 
severity of cognitive impairment, independent of age, 
education and other key confounders. The prevalence of 
global cognitive impairment in persons with CKD was 
more than twice that of the age matched general 
population and was not explained by commonly 
measured metabolic alterations associated with kidney 
disease [3]. Both CKD and chronic dialysis patients are 
thought to be associated with cognitive impairment, but 
cognitive status improves following initiation of dialysis 
and dialysis patients have less cognitive impairment 
compared to untreated patients with advanced uremia as 
shown in our study [6]. Cognitive impairment, 
manifesting typically as a vascular dementia, develops in 
a considerable proportion of patients on dialysis, and 
improves with renal transplantation [14]. Murray 2008, 
found that up to 70% of hemodialysis patients aged 55 
years and older have moderate to severe chronic 
cognitive impairment, yet it is largely undiagnosed [15]. 
There was highly significant difference between CKD 
stage  V patients on HD and control groups as regards 
mean values of cognitive function tests score. This  was  
in agreement with the results of Fazekas et al., 1995, who 
conducted his study on 30 subjects with CKD stage V on 
regular hemodialysis and 30 healthy controls, and found 
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that CKD stage V on regular hemodialysis subjects had  
highly significant cognitive impairment (P<0.001) as 
compared with controls [16]. Also our results were 
supported by the results of Sehgal et al., 1997, who 
conducted his study on 336 hemodialysis patients and 
found significant prevalence of cognitive impairment 
among hemodialysis patients compared to controls [17]. 
There were highly significant differences between stages 
III, IV CKD and stage V on hemodialysis as regards 
mean values of cognitive function tests score, these 
results were in agreement with the results of Kurella et 
al., 2004, who conducted his study on 80 subjects with 
CKD stage III, IV and found that cognitive impairment is 
associated with the severity of kidney disease. In 
contrast, Kurella et al., 2004 studied 80 subjects with 
CKD stage V on hemodialysis with a mean age+/-
standard deviation of 62.5+/-14.3. Three standardized 
cognitive tests, the modified mini-mental state 
examination (3MS), trailmaking test B (trails B), and 
California Verbal Learning Trial (CVLT) were applied. 
Mean scores on the 3MS, trails B, and CVLT immediate 
and delayed recall were significantly worse for subjects 
with stage V on HD than for subjects with CKD or 
published norms [3]. The difference from our results in 
HD patients may be due to advanced age population 
selected in their study. Murray, 2008 found that 
conventional hemodialysis may induce recurrent 
episodes of acute cerebral ischemia, which, in turn, may 
contribute to acute decline in cognitive function during 
dialysis. Thus, the worst time to communicate with 
dialysis patients may be during the hemodialysis session. 
Symptomatic and occult, and subclinical ischemic 
cerebrovascular diseases appear to play a large role in a 
proposed model of accelerated vascular cognitive 
impairment in these populations. Severe cognitive 
impairment among hemodialysis patients is associated 
with an approximately 2-fold increased risk of both 
mortality and dialysis withdrawal. So awareness of 
cognitive function in dialysis patients improves quality 
of care and outcomes by raising clinicians' awareness of 
the potential effects of cognitive impairment on 
medication, fluid, and dietary compliance [15]. 
As regards to severity of CKD our results were supported 
by that of  Kurella et al., 2005, who conducted his study 
on 1015 CKD women, and found that cognitive 
impairment is associated with CKD and increases with 
decreasing kidney function [4].  Khatri et al., 2009, 
found that decreased kidney function is associated with 
greater cognitive decline, even in those with mild CKD 
so kidney disease may represent a novel mechanism 
leading to cognitive impairment and a target for early 
intervention [18]. Thorleif et al., 2009 found that 
moderate-to-severe impaired renal function
 
is associated 
with incident cognitive impairment initially and after 2 
years
 
in a large cohort of elderly subjects [19]. Minesh et 
al., 2009 found that participants with a creatinine 
clearance (CCl) 60 ml/min and those with a CCl between 
60 and 90 ml/min performed significantly worse on the 
modified Telephone Interview for Cognitive Status over 
time than those with a CCl 90 ml/min, decreased kidney 
function associates with greater cognitive decline, even 
in those with mild CKD [20]. 
As regards to hemoglobin, there was significant 
correlation between hemoglobin level and cognitive 
function tests in CKD stage III, IV, V on HD and also 
AKI patients. This was in agreement with the results of 
Lee et al., 2004 who conducted his study on 56 ESRD on 
regular hemodialysis, and found that correction of 
anemia in ESRD has been shown to improve cognitive 
performance [11]. Our results also were in agreement 
with that of Marsh et al., 1991, who found improvement 
in cognitive performance in TMT-B, and D.SYM test 
with increased hemoglobin level in ESRD [21]. Also 
supported by that of Brickman et al., 1996,  who 
conducted  his  study on 426  hemodialysis  patients  and 
Madan et al., 2007 who enrolled patients each of CKD 
stage 3, 4 and 5 (undialysed), they found significant 
correlation between hemoglobin level and cognitive 
performance [22,23]. 
In our study, we were the first to follow cognitive 
performance in AKI patients at the insult and after 
recovery and stabilization of renal function tests and we 
found significant differences in cognitive performance at 
the insult and after recovery, suggesting that AKI per say 
impair cognitive performance and that the uremic toxins 





There were significant differences of cognitive function 
tests results between CKD, III,IV,V, AKI patients as 
compared with healthy group, suggesting that kidney 
disease affects cognitive performance, there were 
significant differences of cognitive function tests results 
between stage III CKD and stage IV CKD, suggesting 
that the severity of cognitive impairment is associated 
with the severity of  CKD, also significant differences of 
cognitive function tests results between CKD and ESRD 
on hemodialysis, suggesting that dialysis improves 
cognitive performance. Our results showed significant 
differences of cognitive function tests results between 
AKI patients at the insult and after recovery, suggesting 
that AKI also impair cognitive function. Finally 
cognitive performance is affected by hemoglobin level, 
suggesting that treatment of anemia in CKD and ESRD 
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